The effects of mitotane and 1α,25-dihydroxyvitamin D
Autor: | B, Rubin, C, Pilon, R, Pezzani, A, Rebellato, F, Fallo |
---|---|
Rok vydání: | 2019 |
Předmět: | |
Zdroj: | Journal of endocrinological investigation. 43(3) |
ISSN: | 1720-8386 |
Popis: | Mitotane is the only chemotherapeutic agent available for the treatment of adrenocortical carcinoma (ACC), however, the anti-neoplastic efficacy is limited due to several side-effects in vivo. There is, therefore, a need of exploring for new anti-tumoral agents which can be used either alone or in combination with mitotane. The active vitamin D metabolite 1α,25-dihydroxyvitamin DMultiple concentrations of mitotane and 1α,25(OH)Our results show an additive effect of mitotane and 1α,25(OH) |
Databáze: | OpenAIRE |
Externí odkaz: |